| 
					时间 TIME
				 | 
					内容 CONTENTS
				 | 
		
			| 
					10月19日(四) (Oct 19,Thursday)
				 | 
		
			| 
					09:00-12:00
				 
					13:30-16:30
				 | 
					培训班2    Workshop 2(复旦枫林校区,Fenglin Campus Fudan): 高级经济学评价Advanced Economic Evaluation上午 Morning:施李正 Dr. Lizheng Shi;下午 Afternoon:陈英耀 Dr. Yingyao Chen
 | 
		
			| 
					10月20日 (五) (Oct 20,Friday)
				 | 
		
			| 
					09:00-12:00
				 
					13:30-16:30
				 | 
					培训班1 Workshop 1(大华虹桥假日酒店Dahua Holiday Inn): 卫生技术评估(HTA)101Health Technology Assessment    (HTA) 101
 Dr.    Clifford Goodman
 翻译 Interpreters:贺尧 Yao He
 | 
					培训班2    Workshop 2(复旦枫林校区,Fenglin Campus Fudan): 高级经济学评价Advanced Economic Evaluation
 上午 Morning:施李正 Dr. Lizheng Shi;
 下午 Afternoon:宣建伟 Dr. Jianwei Xuan
 | 
		
			| 
					17:00-18:30
				 | 
					卫星会(大华虹桥假日酒店Dahua Holiday Inn):肿瘤免疫治疗的卫生技术评估(同传Simultaneous    Interpretation)1.韩宝惠 Dr. Baohui Han:肿瘤免疫治疗在肺癌中的临床价值介绍 IO Therapy Value in Lung Cancer TreatmentSatellite Session: HTA of Immuno-oncology (IO)
 主持    Chair:陈英耀 Dr. Yingyao Chen
 讲者    Speakers:
 2.张启仁Dr. Chee-Jen Chang:肿瘤免疫治疗价值评估国际经验International Experience of Value Assessment in IO
 
 
					3.Dr.    Dierk Neugebauer:肿瘤免疫治疗:企业与政府合作提升患者支付能力Industrial Partnership with    the Government to Improve Patients' Affordability for IO
 | 
		
			| 
					10月21日(六) (Oct 21,Saturday)
				 | 
		
			| 
					08:30-08:50
				 | 
					开 幕 式 Opening Ceremony(同传Simultaneous Interpretation)1.邀请中,国家卫生计生委, National Health and Family Planning Commission领导致辞 Speakers:
 2.邀请中,上海市卫生计生委 Shanghai Health and Family Planning Commission
 3.邀请中,上海市人保局 Shanghai Municipal Human Resources and Social Security Bureau
 4.邀请中,复旦大学公共卫生学院  School of    Public Health, Fudan University
 
 | 
		
			| 
					8:50-10:15
				 | 
					国际HTA发展经验 HTA Experience from    Developed Countries(同传Simultaneous Interpretation)
				1.Dr. Guy Maddern:外科HTA的澳大利亚经验 HTA and Surgery: the Australian    Experience 2.Dr. Brian O’Rourke:HTA与加拿大卫生服务系统 The Role of Health    Technology Assessment in the Canadian Health Care System
 3.Dr. Wija Oortwijn:综合性HTA的发展和决策制定的优化 Towards Integrated HTA    and Improved Decision Making
 
 | 
		
			| 
					10:15-10:45
				 | 
					拍 照  Taking a group picture茶 歇  Tea Break
 | 
		
			| 
					10:45-12:00
				 | 
					中国HTA实践进展 HTA Application in    China(同传Simultaneous Interpretation)
				1.白飞 Fei Bai:大数据与HTA, Big Data and HTA 2.施李正 Dr. Lizheng Shi:糖尿病健康经济模型的构建思路和实践    Design and Application of Health Economic Models for Diabetes
 3.宣建伟 Dr. Jianwei Xuan:中国卫生技术评估实践进展    Progress of HTA Application in China
 
 | 
		
			| 
					12:00-13:30
				 | 
					午 餐  Lunch
				 | 
		
			| 
					13:30-15:00
				 | 
					卫生技术评估在决策中的应用 (案例与讨论)HTA in Decision-making (Case, panel discussion)(同传Simultaneous Interpretation)薛迪 Dr. Di Xue:肝癌热消融治疗技术 Thermal Ablation for Liver Cancer
 研究者、产业、药监、卫生计生、医保、医生、HTA和社会代表讨论 Discussion among representatives of researchers,    industry, drug administration, health and family planning commission, health    insurance, health providers, HTA, and patient representatives.
 | 
		
			| 
					15:00-15:15
				 | 
					茶 歇  Tea Break
				 | 
		
			| 
					15:15-16:45
				 | 
					分会场一(同传)1.宣建伟 Dr. Jianwei Xuan:创新药物HTA的决策框架:如何展现创新药物的价值    Innovative Pharmaceuticals and HTA – How to Demonstrate the Value of Innovative    Medicine: A Decision Making Framework(Simultaneous Interpretation)
 专题分会 Parallel Session
 创新药物的市场准入和保险报销
 Innovative    Medicine Market Access and Reimbursement Listing
 讲者 Speakers:
 2.施强 Dr. Qiang Shi:真实世界案例运用于创新药物HTA的国际经验International Experience: Real    World Cases of Innovative Pharmaceuticals/HTA Applications in Selected Countries
 3.杨莉 Dr. Li Yang:真实世界案例运用于创新药物HTA的中国经验 China Experience: Real World    Cases of Innovative Pharmaceuticals/HTA Applications in China
 
 | 
					分会场二1.Dr. Wija Oortwijn:事实与价值、HTA与伦理:关于同一主题的两种文化还是两个方面?Facts    and Values, HTA and Ethics: Two Cultures or Two Aspects of the Same Thing?专题分会 Parallel Session
 HTA中的伦理评价
 Ethical    Evaluation in HTA(同传)
 (Simultaneous Interpretation)
 讲者 Speakers:
 2.薛迪 Dr. Di Xue:公共卫生伦理 Public Health Ethics
 3.周萍 Dr. Ping Zhou:儿童基因检测与基因测序的伦理思辨Ethical    issues and considerations in genetic testing and sequencing of    children
 
 | 
					分会场三1.石磊玉 Dr. Leiyu Shi:卫生技术评估和初级保健 Health Technology Assessment    and Primary Care专题分会 Parallel Session
 服务体系与HTA
 HTA in the Health Care System
 讲者 Speakers:
 2.诸宏明 Dr. Hongming    Zhu:基层卫生现状、发展及挑战Status Quo, Development, and Challenges of Primary    Health Care
 3.于浩 Dr. Hao Yu:美国医疗事故法律的改革和影响    Medical Malpractice Laws in the U.S.: Reforms and Impacts
 
 | 
					分会场四1.王向东 Dr. Xiangdong Wang:精准医学在临床中应用 Clinical Application of    Precision Medicine专题分会 Parallel Session
 精准医疗
 Precision    Medicine
 讲者 Speakers:
 2.刘宝 Dr. Bao Liu:精准医疗的经济学评价 Economic    Evaluation in Precision Medicine
 3.陈英耀Dr. Yingyao Chen:基因检测技术和卫生技术评估    Genetic testing and HTA
 
 | 
					
 | 
		
			| 
					17:00-18:00
				 | 
					分会场一口头汇报1
 Oral Presentation 1
 1.门鹏
 氨磺必利和奥氮平治疗中国精神分裂症患者的有效性、安全性和成本比较:系统评价、荟萃分析和最小成本分析
 2.魏艳
 卡泊芬净与伏立康唑在中性粒细胞缺乏伴发热患者中初始经验性抗真菌治疗的经济学评价
 3.杨帆
 西达本胺治疗外周T细胞淋巴瘤药物经济学研究
 4.朱水清
 左心耳封堵术对比华法林预防房颤患者血栓栓塞的卫生经济学评价
 5.孙辉
 琥珀酰明胶及羟乙基淀粉扩充血容量的卫生经济学研究
 | 
					分会场二口头汇报2
 Oral Presentation 2
 1.林森林
 上海市学龄儿童近视筛查策略评价
 2.余秋丽
 高发区移民人群食管癌早诊早治方案的卫生经济学评价
 3.金辉
 基于系统力学模型的戊型肝炎干预策略研究
 4.刘世蒙
 中国农村地区宫颈癌筛查偏好研究---基于离散选择实验分析
 5.吴昱杉
 香港二型糖尿病筛查的成本效益模拟分析
 | 
					分会场三口头汇报3
 Oral Presentation 3
 1.李顺平
 Health State Utilities and    Subjective Well-being among Psoriasis Vulgaris Patients in Mainland China
 2.陈晓炜
 不可逆电穿孔技术治疗恶性肿瘤的早期评估
 3.张蕾
 采用压力感应导管射频消融对比一代冷冻球囊消融治疗阵发性房颤的成本效果研究
 4.贾莉英
 卡非佐米治疗多发性骨髓瘤的效果:系统评价
 | 
					分会场四口头汇报4
 Oral Presentation 4
 1.林海
 引入大数据支持的“药物利用研究”推进合理用药:上海市抗菌药使用监测的例子
 2.韩思蒙
 Individualized Medicine    and its Applications in Clinical Decision-Making and Health Technology    Assessment
 3.张研
 医保大数据在居民医疗服务利用评估与监测中的应用
 4.熊尧
 国内药物治疗预算影响分析的系统评价
 5.林夏
 关于在我国发展医院卫生技术评估的思考
 | 
					
 | 
		
			| 
					10月22日(日) (Oct 22,Sunday)
				 | 
		
			| 
					08:30-10:00
				 | 
					分会场一(同传)1.吴朝晖 Zhaohui Wu:新技术评估的挑战和作用 Challenges and Uses of    HTA for Emerging Technology(Simultaneous Interpretation)
 专题分会 Parallel Session
 新技术HTA
 HTA for Emerging Technology
 讲者 Speakers:
 2.Dr. Clifford Goodman:如何改变HTA以应对新技术呈现的挑战 Adapting HTA to Meet the    Challenges of Emerging Technologies
 3.Dr. Don Juzwishin:实现技术最大价值:创新管理卫生系统采购、供应链和生命周期 Innovating Health System Procurement and Supply Chain: Managing the    Life Cycle of Technology for Maximum Value
 
 | 
					分会场二1.涂诗意 Dr. Shiyi Tu:多准则决策分析在医保目录药品遴选中的应用    Application of Multi-criteria Decision Analysis in Drug Selection for Medical    Insurance Benefit Package专题分会 Parallel Session
 政策转化
 Policy Translation
 讲者 Speakers:
 2.张勘 Dr Kan Zhang:HTA与政策转化-决策者的视角HTA and Policy    Translation: A Decision Maker’s Perspective
 3.张亮 Dr. Liang Zhang: 中国健康政策研究的转化:研究背景及研究效用    Translation of Health Policy Research in China: Background and Utility of    Research
 
 | 
					分会场三1.孙鑫 Dr. Xin Sun:外科医疗技术的临床研究与评价    Clinical Research and Evaluation of Medical Technologies in Surgery专题分会 Parallel Session
 循证医学
 Evidence-based Medicine
 讲者 Speakers:
 2.杨克虎 Dr. Kehu Yang:GRADE与HTA,GRADE (Grading of    Recommendations Assessment, Development and Evaluation) and HTA
 3.Dr. Alex Wang:为老年痴呆患者提供以人为本的治疗 Person-centred Care for People    with Dementia
 
 | 
					分会场四1.宣建伟 Dr. Jianwei Xuan:中国医疗大数据库及其在临床决策中的应用    Medical Big Database in China and Application to Support Clinical Decision Making专题分会 Parallel Session
 大数据和HTA Medical Big Data Construction and Application in HTA
 讲者 Speakers:
 2.许速 Su Xu:医疗大数据在行政管理及决策中的应用    Application of Medical Big Data in Public Administration and Decision Making
 3.谷成明 Dr.    Chengming Gu:医疗大数据在临床诊疗决策中的应用 Application of Medical Big Data in Clinical    Decision Making
 
 | 
					
 | 
		
			| 
					10:00-10:20
				 | 
					茶 歇  Tea Break
				 | 
					
 | 
		
			| 
					10:20-11:50
				 | 
					分会场一(同传)1.李秀娟 Xiujuan Li:基于卫生技术评估的医保支付管理HTA-based Health Insurance Reimbursement    Management(Simultaneous Interpretation)
 专题分会    Parallel Session
 医疗保险
 Medical Insurance
 讲者 Speakers:
 2.应晓华 Dr. Xiaohua Ying:医保准入中的HTA视角 Entry to the National    Reimbursement Drug List: an HTA Perspective
 3.待定
 
 | 
					分会场二1.石菊芳 Dr. Jufang Shi:人群癌症筛查的卫生技术评估 HTA of Population-based Cancer Screening专题分会 Parallel Session
 公共卫生
 Public health
 讲者 Speakers:
 2.阚海东 Dr. Haidong Kan:雾霾防护产品的技术评估进展 Progress in the Technology Assessment of Smog    Protection Products
 3.吕军 Dr. Jun Lv:新生儿筛查的卫生技术评估 HTA of Neonatal Screening
 4.黄葭燕 Dr. Jiayan Huang:疟疾快速诊断技术的经济学评价:基于非流行区数据 Economic Evaluation of Rapid    Diagnosis of Malaria: A Study based on Data from Non-endemic Areas
 
 | 
					分会场三专题分会 Parallel Session
 HTA与决策
 HTA and Decision Making
 讲者 Speakers:
 1.宣建伟 Dr. Jianwei    Xuan: 心力衰竭的疾病负担 Disease Burden of Heart Failure
 2. 司志超 Zhichao Si:复发或难治性慢淋/套淋的治疗选择及展望 Potential breakthrough    treatment in rrCLL&rrMCL
 3. 王薇 Dr. Wei Wang:比较肝切除术和肝移植对治疗符合米兰标准的早期原发性肝细胞癌的成本效益分析 Comparison between Hepatectomy and Liver    Transplantation for Early Primary Hepatocellular Carcinomas that Meet the    Milan Criteria: A Cost-effectiveness Analysis
 | 
					分会场四1.杨海 Hai Yang:医院卫生技术评估中国案例 Case Study of Hospital-based HTA    in China专题分会 Parallel Session
 医院HTA
 Hospital-based HTA
 讲者 Speakers:
 2.何江江 Jiangjiang He:欧盟AdHopHTA项目对中国发展医院卫生技术评估的启示 Lessons    for Developing Hospital-based HTA in China from the EU AdHopHTA Project
 3.杨毅恒 Yiheng Yang:卫生技术评估与医院新药遴选    HTA and Hospital Selection of New Drugs
 4.柳睿 Rui Liu:医药RWE与卫生技术评估的企业探索 Pharmaceutical    Real-world Evidence (RWE) and HTA: A Corporate Perspective
 
 | 
					分会场五1.Noah    Friedman: 价值医疗的理念、在发达国家的实践及对中国的启示 Value-based health care: the concept,    practice in developed countries, and lessons for China专题分会 Parallel Session
 价值医疗
 Value-based Health Care
 主题演讲 Keynote speeches:
 2.Magen    Xia: 创新的医疗保险支付方式引导价值医疗——国际经验分享及对中国启示 Innovative health insurance    payment methods guide value-based health care: international experience and    lessons for China
 3.张杰 Jie Zhang:医保支付的价值引导 Guiding    the values of health insurance reimbursement
 
 
					专题讨论 Panel discussion:
				1.Noah    Friedman: 2.Magen    Xia
 3.医疗保险支付方代表 Payer representative
 
 
					4.医疗监管方代表 Healthcare administration    representative
				 | 
		
			| 
					12:00-12:30
				 | 
					闭 幕 式  Closing Ceremony(同传)(Simultaneous Interpretation)
				 | 
		
			| 
					13:30-17:00
				 | 
					培训班1 Workshop    1(大华虹桥假日酒店Dahua Holiday Inn):
 如何应对卫生技术评估和创新中的挑战 Health Technology Assessment and Innovation: Addressing the Challenges
 Dr. Don Juzwishin
 翻译    Interpreters:王薇 Dr. Wei Wang
 | 
					2017年度重点实验室学术委员会会议 2017 Key Lab Advisory Committee    Meeting(大华虹桥假日酒店2楼馨华厅)
 | 
					重点实验室2017年度开放课题中期考核会议2017 Key Lab Open Project    Midterm Evaluation Meeting(大华虹桥假日酒店2楼嘉华厅)
 | 
					培训班3    Workshop 3(复旦枫林校区Fenglin Campus Fudan):
 系统评价Cochrane    workshop Dr. Alex Wang
 郑英杰
 |  | 
		
			| 
					10月23日(一) (Oct 23,Monday)
				 | 
		
			| 
					09:00-12:00
				 | 
					培训班1 Workshop    1: 卫生技术评估和实施中适用和不适用的方法 Health Technology    Assessment and Implementation: What Works and What Does NotDr. Don Juzwishin
 翻译    Interpreters:王薇 Dr. Wei Wang
 | 
					培训班3    Workshop 3(复旦枫林校区,Fenglin Campus Fudan):
 系统评价Cochrane    workshop
 Dr.    Alex Wang
 Dr.    Vanessa Jordan
 | 
		
			| 
					13:00-17:00
				 | 
					培训班3    Workshop 3(复旦枫林校区,Fenglin Campus Fudan):系统评价Cochrane    workshop
 Dr.    Alex Wang
 Dr.    Vanessa Jordan
 | 
		
			| 
					10月24日(二) (Oct 24,Tuesday)
				 | 
		
			| 
					09:00-17:00
				 | 
					培训班3    Workshop 3(复旦枫林校区,Fenglin Campus Fudan):系统评价Cochrane    workshop
 Dr.    Alex Wang
 Dr.    Vanessa Jordan
 |